North America Clinical Trials 麻豆原创 2021-2031 by Product Category , Phase , Design , Service Type , Indication , End User, and Country: Trend Forecast and Growth Opportunity

You are here: 麻豆原创 Catalog Pharma & Healthcare Clinical Trials Country Overview (Pharma & Healthcare)

North America Clinical Trials 麻豆原创 2021-2031 by Product Category , Phase , Design , Service Type , Indication , End User, and Country: Trend Forecast and Growth Opportunity

麻豆原创 Research Report Summary

North America Clinical Trials 麻豆原创 2021-2031 by Product Category , Phase , Design , Service Type , Indication , End User, and Country: Trend Forecast and Growth Opportunity report is published on March 31, 2022 and has 136 pages in it. This market research report provides information about Clinical Trials, Country Overview (Pharma & Healthcare), Pharma & Healthcare industry. It covers North America market data and forecasts. It is priced starting at USD 3,200.00 for Single User License (PDF) which allows one person to use this report.

Please read the description and table of contents of this research report given below to check whether it meets your research requirements. If not, then please do not hesitate to contact us using "Report Enquiry" form given below. We can customize this research report or suggest a new fully customized market research report to meet your research goals and data requirements.

North America Clinical Trials 麻豆原创 2021-2031 by Product Category , Phase , Design , Service Type , Indication , End User, and Country: Trend Forecast and Growth Opportunity

Printer version

Send by email

Publication ID:听

GRM0322030

Publication Date:听

March 31, 2022

笔补驳别蝉:听

136

笔耻产濒颈蝉丑别谤:听

Grace 麻豆原创 Data

颁辞耻苍迟谤颈别蝉:听

North America

USD 3,200.00

Pay By Invoice

If you wish to purchase this report using bank/wire transfer against an invoice, please fill your details using request invoice form given below.

Globally Trusted Brand

We help executives from firms听to Start-ups听with their market research needs thus听we can help you too.听

Secure Checkout

You can shop confidently as your online payments are processed using PCI DSS compliant secure payment gateways on our website.

Frequently Asked Questions

If you have any pre-sales听questions related to this report please let us know using the "Report Enquiry" form below. This will help us provide you听with answers听so that you can purchase with confidence. If you wish to read about frequently asked questions by our customers please visit our .

Tabs

Description

North America clinical trials market is projected to grow by 6.9% annually in the forecast period and reach $ 39,268.7 million by 2031, driven by the increasing number of clinical trials and increase in demand for novel therapies, rising prevalence on chronic diseases such as cancer and diabetes, the outbreak of tropical and infectious diseases such as COVID-19, and the increase in government initiatives and R&D investments.
Highlighted with 29 tables and 75 figures, this 136-page report 鈥淣orth America Clinical Trials 麻豆原创 2021-2031 by Product Category (Drugs, Devices, Procedures), Phase (I, II, III, IV), Design (Interventional, Observational, Expanded Access), Service Type (Site Identification, Lab Services, Supply & Logistic, Decentralized Services), Indication (Oncology, Infectious Diseases, Cardiology, Obesity, Diabetes, Neurology), End User, and Country: Trend Forecast and Growth Opportunity鈥� is based on a comprehensive research of the entire North America clinical trials market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:
鈥� 麻豆原创 Structure
鈥� Growth Drivers
鈥� Restraints and Challenges
鈥� Emerging Product Trends & 麻豆原创 Opportunities
鈥� Porter鈥檚 Fiver Forces
The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify North America clinical trials market in every aspect of the classification from perspectives of Product Category, Phase, Design, Service Type, Indication, End User, and Country.

Based on Product Category, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
鈥� Trials of Drugs
o Small Molecule Drugs
o Vaccines
o Cell & Gene Therapy
o Other Drugs
鈥� Trials of Devices
鈥� Trials of Procedures

Based on Phase, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
鈥� Phase I
鈥� Phase II
鈥� Phase III
鈥� Phase IV

By Design, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
鈥� Interventional Studies
o Randomized Control Trial
o Adaptive Clinical Trial
o Non-randomized Control Trial
鈥� Observational Studies
o Cohort Study
o Case Control Study
o Cross Sectional Study
o Ecological Study
鈥� Expanded Access Trials

By Service Type, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
鈥� Protocol Designing
鈥� Site Identification
鈥� Patient Recruitment
鈥� Laboratory Services
鈥� Bioanalytical Testing Services
鈥� Clinical Trial Data Management Services
鈥� Clinical Trial Supply & Logistic Services
鈥� Decentralized Clinical Trial Services
鈥� Medical Device Testing Services
鈥� Other Clinical Trial Services

By Indication, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
鈥� Oncology
鈥� Infectious Diseases
鈥� Cardiology
鈥� Obesity
鈥� Diabetes
鈥� Neurology
鈥� Immunology
鈥� Pain Management
鈥� Other Indications

By End User, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
鈥� Pharmaceutical and Biotechnological Companies
鈥� Clinical Research Organizations
鈥� Clinical Testing Laboratories
鈥� Other End Users

Geographically, the following national/local markets are fully investigated:
鈥� U.S.
鈥� Canada
鈥� Mexico
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Phase, Design, and Indication over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Accell Clinical Research LLC
Charles River Laboratory
ClinDatrix Inc
Clinipace
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
ICON PLC
IQVIA Holdings, Inc.
Laboratory Corporation of America
Novo Nordisk AS
PAREXEL International Corporation
Pfizer Inc.
Pharmaceutical Product Development LLC
PRA Health Sciences
Sanofi SA
SGS SA
Syneos Health Inc.
Wuxi AppTec Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Table of Contents

1 Introduction 8
1.1 Industry Definition and Research Scope 8
1.1.1 Industry Definition 8
1.1.2 Research Scope 9
1.2 Research Methodology 12
1.2.1 Overview of 麻豆原创 Research Methodology 12
1.2.2 麻豆原创 Assumption 13
1.2.3 Secondary Data 13
1.2.4 Primary Data 13
1.2.5 Data Filtration and Model Design 14
1.2.6 麻豆原创 Size/Share Estimation 15
1.2.7 Research Limitations 16
1.3 Executive Summary 17
2 麻豆原创 Overview and Dynamics 20
2.1 麻豆原创 Size and Forecast 20
2.1.1 Impact of COVID-19 on World Economy 22
2.1.2 Impact of COVID-19 on the 麻豆原创 24
2.2 Major Growth Drivers 26
2.3 麻豆原创 Restraints and Challenges 33
2.4 Emerging Opportunities and 麻豆原创 Trends 36
2.5 Porter鈥檚 Fiver Forces Analysis 40
3 Segmentation of North America 麻豆原创 by Product Category 44
3.1 麻豆原创 Overview by Product Category 44
3.2 Trials of Drugs 46
3.2.1 Small Molecule Drugs 47
3.2.2 Vaccines 48
3.2.3 Cell & Gene Therapy 49
3.2.4 Other Drugs 50
3.3 Trials of Devices 51
3.4 Trials of Procedures 52
4 Segmentation of North America 麻豆原创 by Phase 53
4.1 麻豆原创 Overview by Phase 53
4.2 Phase I 55
4.3 Phase II 56
4.4 Phase III 57
4.5 Phase IV 58
5 Segmentation of North America 麻豆原创 by Design 59
5.1 麻豆原创 Overview by Design 59
5.2 Interventional Studies 61
5.2.1 Randomized Control Trial 63
5.2.2 Adaptive Clinical Trial 64
5.2.3 Non-randomized Control Trial 65
5.3 Observational Studies 66
5.3.1 Cohort Study 68
5.3.2 Case Control Study 69
5.3.3 Cross Sectional Study 70
5.3.4 Ecological Study 71
5.4 Expanded Access Trials 72
6 Segmentation of North America 麻豆原创 by Service Type 73
6.1 麻豆原创 Overview by Service Type 73
6.2 Protocol Designing 75
6.3 Site Identification 76
6.4 Patient Recruitment 77
6.5 Laboratory Services 78
6.6 Bioanalytical Testing Services 79
6.7 Clinical Trial Data Management Services 80
6.8 Clinical Trial Supply & Logistic Services 81
6.9 Decentralized Clinical Trial Services 82
6.10 Medical Device Testing Services 83
6.11 Other Clinical Trial Services 84
7 Segmentation of North America 麻豆原创 by Indication 85
7.1 麻豆原创 Overview by Indication 85
7.2 Oncology 87
7.3 Infectious Diseases 88
7.4 Cardiology 89
7.5 Obesity 90
7.6 Diabetes 91
7.7 Neurology 92
7.8 Immunology 93
7.9 Pain Management 94
7.10 Other Indications 95
8 Segmentation of North America 麻豆原创 by End User 96
8.1 麻豆原创 Overview by End User 96
8.2 Pharmaceutical and Biotechnological Companies 98
8.3 Clinical Research Organizations 99
8.4 Clinical Testing Laboratories 100
8.5 Other End Users 101
9 North America 麻豆原创 2021-2031 by Country 102
9.1 Overview of North America 麻豆原创 102
9.2 U.S. 105
9.3 Canada 108
9.4 Mexico 110
10 Competitive Landscape 112
10.1 Overview of Key Vendors 112
10.2 New Product Launch, Partnership, Investment, and M&A 116
10.3 Company Profiles 117
Accell Clinical Research LLC 117
Charles River Laboratory 119
ClinDatrix Inc 120
Clinipace 121
Eli Lilly and Company 122
F. Hoffmann-La Roche Ltd. 123
ICON PLC 124
IQVIA Holdings, Inc. 125
Laboratory Corporation of America 126
Novo Nordisk AS 127
PAREXEL International Corporation 128
Pfizer Inc. 129
Pharmaceutical Product Development LLC 130
PRA Health Sciences 131
Sanofi SA 132
SGS SA 133
Syneos Health Inc. 134
Wuxi AppTec Inc. 135
RELATED REPORTS 136

Companies Covered

Selected Key Players:
Accell Clinical Research LLC
Charles River Laboratory
ClinDatrix Inc
Clinipace
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
ICON PLC
IQVIA Holdings, Inc.
Laboratory Corporation of America
Novo Nordisk AS
PAREXEL International Corporation
Pfizer Inc.
Pharmaceutical Product Development LLC
PRA Health Sciences
Sanofi SA
SGS SA
Syneos Health Inc.
Wuxi AppTec Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Report License Types

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

Enquiry / Request Invoice

Report Inquiry

Do you have more questions related to this market research report after going through the description and table of contents?

We are here to help. Please use the form given below to let us know your questions related to this report.

Kindly use your official email address and contact number to ensure speedy response.

First Name *

Last Name *

Company *

Email Address *

Phone (Including International Code) *

Report Title *

Do you need invoice for purchasing this report? *

Address 1

Address 2

City/Town

Postal/Zip Code

Country

License Type

Your Inquiry *

CAPTCHA

This question is for testing whether you are a human visitor and to prevent automated spam submissions.

Clinical Trials

Country Overview (Pharma & Healthcare)

Pharma & Healthcare

*Please note that the report cover image shown above is for representation purpose only. Actual report cover may vary.

听

Related 麻豆原创 Research Reports

Publication	Price
Global Clinical Trials 麻豆原创 2021-2031 by Product Category , Phase , Design , Service Type , Indication , End User, and Region: Trend Forecast and Growth Opportunity Global clinical trials market will reach $ 79,977.1 million by 2031, growing by 6.8% annually over 2021-2031, driven by the increasing number of clinical trials and increase in demand for novel therapies, rising prevalence on chronic diseases such as cancer and diabetes, the outbreak of tropical and infectious diseases such as COVID-19, and the increase in government initiatives and R&D investments. Highlighted with 88 tables and 111 figures, this 198-page report 鈥淕lobal Clinical Trials 麻豆原创 2021-2031 by Product Category (Drugs, Devices, Procedures), Phase (I, II, III, IV), Design (Interventional, Observational, Expanded Access), Service Type (Site Identification, Lab Services, Supply & Logistic, Decentralized Services), Indication (Oncology, Infectious Diseases, Cardiology, Obesity, Diabetes, Neurology), End User, and Region: Trend Forecast and Growth Opportunity鈥� is based on a comprehensive research of the entire global clinical trials market and all its sub-...Read more	USD 3,800.00
Europe Clinical Trials 麻豆原创 2021-2031 by Product Category , Phase , Design , Service Type , Indication , End User, and Country: Trend Forecast and Growth Opportunity Europe clinical trials market was valued at $10,471.1 million in 2021 and will grow by 6.2% annually over 2021-2031, driven by the increasing number of clinical trials and increase in demand for novel therapies, rising prevalence on chronic diseases such as cancer and diabetes, the outbreak of tropical and infectious diseases such as COVID-19, and the increase in government initiatives and R&D investments. Highlighted with 39 tables and 79 figures, this 142-page report 鈥淓urope Clinical Trials 麻豆原创 2021-2031 by Product Category (Drugs, Devices, Procedures), Phase (I, II, III, IV), Design (Interventional, Observational, Expanded Access), Service Type (Site Identification, Lab Services, Supply & Logistic, Decentralized Services), Indication (Oncology, Infectious Diseases, Cardiology, Obesity, Diabetes, Neurology), End User, and Country: Trend Forecast and Growth Opportunity鈥� is based on a comprehensive research of the entire Europe clinical trials market and all its...Read more	USD 3,200.00
Asia Pacific Clinical Trials 麻豆原创 2021-2031 by Product Category , Phase , Design , Service Type , Indication , End User, and Country: Trend Forecast and Growth Opportunity Asia Pacific clinical trials market will grow by 8.2% annually with a total addressable market cap of $104,282.0 million over 2022-2031, driven by the increasing number of clinical trials and increase in demand for novel therapies, rising prevalence on chronic diseases such as cancer and diabetes, the outbreak of tropical and infectious diseases such as COVID-19, and the increase in government initiatives and R&D investments. Highlighted with 36 tables and 78 figures, this 142-page report 鈥淎sia Pacific Clinical Trials 麻豆原创 2021-2031 by Product Category (Drugs, Devices, Procedures), Phase (I, II, III, IV), Design (Interventional, Observational, Expanded Access), Service Type (Site Identification, Lab Services, Supply & Logistic, Decentralized Services), Indication (Oncology, Infectious Diseases, Cardiology, Obesity, Diabetes, Neurology), End User, and Country: Trend Forecast and Growth Opportunity鈥� is based on a comprehensive research of the entire Asia Pacific...Read more	USD 3,200.00
World Anorexia Nervosa Clinical Trials 麻豆原创 Research Report 2025 (covering USA, Europe, China, Japan, India, South East Asia and etc) Summary Anorexia Nervosa Clinical Trials market research report provides the newest industry data and industry future trends, allowing you to identify the products and end users driving Revenue growth and profitability. The industry report lists the leading competitors and provides the insights strategic industry Analysis of the key factors influencing the market. The report includes the forecasts, Analysis and discussion of important industry trends, market size, market share estimates and profiles of the leading industry Players. Global Anorexia Nervosa Clinical Trials 麻豆原创: Product Segment Analysis For All Only for children under 18 yrs Global Anorexia Nervosa Clinical Trials 麻豆原创: Application Segment Analysis Global Anorexia Nervosa Clinical Trials 麻豆原创: Regional Segment Analysis USA Europe Japan China India South East Asia The Players mentioned in our report ANRED ...Read more	USD 2,960.00
Mobile Health (mHealth) Technologies: Global 麻豆原创 Prospects - Featuring Expert Panel Views from Industry Survey 2017 Mobile Health (mHealth) Technologies: Global 麻豆原创 Prospects - Featuring Expert Panel Views from Industry Survey 2017 Summary GBI Research鈥檚 latest report Mobile Health (mHealth) Technologies: Global 麻豆原创 Prospects - Featuring Expert Panel Views from Industry Survey 2017 provides a comprehensive analysis of the mHealth landscape. GBI Research conducted an extensive industry survey of 65 experts from the pharmaceutical, medical devices, healthcare and healthcare IT industries - including organizations that already implement mHealth solutions and services, and those that do not. The survey gathered experience and opinion on the use of mHealth, and insights on key trends for the present and future use of these technologies, particularly within the pharmaceutical industry. The findings from the survey and results from secondary research efforts have been amalgamated with GBI鈥檚 own analytical views to provide an assessment that is comprehensive in outlook. ...Read more	USD 2,995.00

Clients Who Trust Us

Need tailor made market research solution? We can help you with that too.

Contact Us

About Us

At 麻豆原创 we aim to make it easier for decision makers to find relevant information and locate right market research reports which can save their time and assist in what they do best, i.e. take time-critical decisions.

We work with our associate Global market research firms who are known leaders in their respective domains to obtain right market research solution for our customer鈥檚 needs, be it custom research or syndicated research reports.

Contact Us

麻豆原创 Research Reports, Inc
16192 Coastal Hwy
Lewes, DE 19958, USA

USA: +1-302-703-9904

India: +91-8762746600

marketresearchreports

info@marketresearchreports.com

Latest Blog Posts

Stay Connected

Disclaimer: 麻豆原创 has no affiliation to, and is not associated with any other website(s) or organization(s). We offer syndicated research reports (like country analysis, SWOT analysis, competitive intelligence, industry reports, company reports and market analysis & trends reports) and custom market research from our website 麻豆原创ResearchReports.com only.

If you are looking for a market research solution for your research requirements, please begin your search using the search box on top of this page or use our chat system to speak to our market research consultants or directly write to us.

麻豆原创